Description
Tesamorelin and Ipamorelin are synthetic peptides that research suggests may influence the synthesis and release of growth hormone. When combined as a blend, these peptides are thought to act synergistically through different receptor pathways related to growth hormone regulation in experimental settings.
Tesamorelin is a modified analog of Growth Hormone‑Releasing Hormone (GHRH). It is believed to bind to GHRH receptors in the anterior pituitary gland, potentially triggering the secretion of growth hormone.
Ipamorelin is a synthetic pentapeptide classified in the growth hormone secretagogue (GHS) group. It appears to mimic aspects of the natural hormone ghrelin by binding to growth hormone secretagogue receptors (GHS‑R1a) in the pituitary gland, which may stimulate the release of growth hormone. Researchers suggest Ipamorelin may be more selective in its action and produce fewer effects on other pituitary hormones compared to other GHS peptides.
When presented together, Tesamorelin and Ipamorelin are thought to potentially exert a synergistic effect on growth hormone release by engaging distinct receptor pathways — Tesamorelin via the GHRH receptors and Ipamorelin via the ghrelin receptors — which could enhance growth hormone pulsatility in research models.
Chemical Makeup
Molecular Formula:
• Tesamorelin: C176H306N52O55
• Ipamorelin: C38H49N9O5
Molecular Weight:
• Tesamorelin: (not specified on page)
• Ipamorelin: 711.8 g/mol
Other Known Titles:
• Tesamorelin: Modified GHRH peptide
• Ipamorelin: NNC 26‑0161
Research and Experimental Context
Tesamorelin + Ipamorelin Blend and Growth Hormone Release
Experimental research has investigated how peptides acting on different hormone regulatory receptors may impact growth hormone secretion. Tesamorelin interacts with growth hormone‑releasing hormone receptors, while Ipamorelin engages ghrelin receptors. When used together in laboratory settings, these peptides are examined for their capacity to potentially increase growth hormone levels through combined mechanisms of action.
Tesamorelin + Ipamorelin Blend and Appetite/Metabolic Signaling
Because Ipamorelin interacts with ghrelin receptors, some research suggests it may influence appetite and metabolic pathways in certain experimental models.
Tesamorelin + Ipamorelin Blend and Body Composition
By potentially stimulating growth hormone release, peptide blends like this have been explored in research for their possible effects on lean body mass, nitrogen balance, and metabolic signaling pathways.
This peptide blend is available for research and laboratory purposes only. Please review and adhere to the Terms and Conditions before ordering.
